“…The MICs of streptomycin, penicillin, ceftriaxone, tetracycline, doxycycline, azithromycin, and ciprofloxacin, in addition to zoliflodacin and gepotidacin (two compounds currently being evaluated in clinical trials for the treatment of gonorrhea) (Taylor, Morris, et al 2018;Taylor, Marrazzo, et al 2018), were determined against N. gonorrhoeae strains CDC-181, CDC-181-rpsLA128G, WHO-X, and WHO-X-rpsLA128G as well as FA 1090 (as a control) using the broth microdilution method as described previously (Alhashimi, Mayhoub, and Seleem 2019;Hewitt et al 2021;Naclerio et al 2021;Seong et al 2020;Giovannuzzi et al 2022). Briefly, a 1.0 McFarland bacterial solution was prepared and diluted in brucella broth supplemented with yeast extract, dextrose, proteose-peptone, NAD, pyridoxal, hematin, and IsoVitaleX to reach an inoculum of ~1×10 6 colony forming units (CFU)/mL.…”